The diagnosis and treatment of primary osteoporosis according to current guidelines;Primäre osteoporose - Leitliniengerechte diagnostik und therapie

Deutsches Arzteblatt

Volumn 105, Issue 33, 2008, Pages 573-582

  Baum, Erika ^a   Peters, Klaus M ^b,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Abteilung für Orthopädie und Osteologie

^c Rhein Sieg Klinik   (Germany)

Author keywords

Compliance; Diagnosis; Guidelines; Osteoporosis; Therapeutic threshold

Indexed keywords

ALENDRONIC ACID; CALCIUM; CARBAMAZEPINE; GLUCOCORTICOID; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D; ZOLEDRONIC ACID;

BONE DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; GENDER; GERMANY; GROUPS BY AGE; HUMAN; KINESIOTHERAPY; MEDICAL LITERATURE; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PRIMARY OSTEOPOROSIS; PROPHYLAXIS; REVIEW; RISK FACTOR; SMOKING; SUN EXPOSURE; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION; WEIGHT BEARING;

EID: 54249086172     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0573     Document Type: Review

References (24)

1. Häussler B, Grote H, Mangiapane S, Glaeske G, Pientka L, Felsenberg D: Versorgung von Osteoporose-Patienten in Deutschland. Dtsch Arztebl 2006; 103(39): A 2542-8.
2. Dachverband der deutschsprachigen wissenschaftlichen osteologischen Gesellschaften für Osteologie (DVO) e.V.: Osteoporose-Leitlinie. Langfassung. Stuttgart, New York: Schattauer 2006.
3. Mackey DC, Lui LY, Cawthorn PM et al.: High-trauma fractures and low bone mineral density in older women and men. JAMA 2007; 298: 2381-8.
4. Peters KM: Osteoporose. In: Bischoff HP, Heisel J, Locher H (Hrsg.): Praxis der konservativen Orthopädie. Stuttgart, New York: Thieme 2007; 468-77.
5. Hillier TA, Stone KL, Bauer DC et al.: Evaluating the value of repeated bone mineral density measurement and prediction of fractures in older women. Arch Intern Med 2007; 167: 155-60.
6. Harada A: Exercise for fall prevention and osteoporosis treatment. Nippon Rinso 2006; 64: 1687-91.
7. Cólon-Emeric CS, Lyles KW, House P et al.: Randomized to improve fracture prevention in nursing home residents. Am J Med 2007; 120: 886-92.
8. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A: Use of calcium or calcium in combination with Vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657-66.
9. Geusens PP, Lems WF: Fracture prevention in postmenopausal women with osteoporosis by annual infusion of zoledronic acid. Ned Tijdschr Geneeskd 2007; 151: 1445-8.
10. Vestergard P, Jorgenson NR, Mosekilde L, Schwarz P: Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk - a meta analysis. Osteoporos Int 2007; 18: 45-57.
11. Jefcoat MK: Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006; 21: 349-53.
12. Haas H, Amling M, Baier M et al.: Zur Anwendung der Ballon-Kyphoplastie/ Vertebroplastie. Osteologie 2008; 17: 11-6.
13. Prince RL, Devine A, Dhaliwal SS, Dick IM: Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006; 166: 869-75.
14. Segal E, Tamir A, Ish-Shalom S: Compliance of osteoporotic patients with different treatment regimens. IMAJ 2003; 5: 859-62.
15. Peters KM, Hasselberg J, Bode M: Compliance der medikamentösen Osteoporosetherapie nach Teilnahme am Osteoporoseschulungsprogramm. Osteologie 2007; 16: 30-1.
16. Peters KM, Bode M: Nümbrechter Osteoporose Schule. Steinkopff 2008.
17. Black DM, Schwartz AV, Ensrud KE et al.: Effects of continuing or stopping Alendronate after 5 years of treatment. JAMA 2006; 296: 2927-38.
18. Gardner MJ, Brophy RH, Demetrakopoulos D: Interventions to improve treatment following hip fracture: a prospective, randomized trial. J Bone Joint Surg Am 2005; 87: 3-7.
19. Morrison LS, Tobias JH: Effect of case-finding strategy for osteoporosis on bisphosphonate prescribing in primary care. Osteoporos Int 2005; 16: 71-7
20. Lacroix AZ, Buist DS, Brennemann SK, Abbott TA: Evluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care 2005; 43: 293-302.
21. Feldstein A, Elmer PJ, Smith DH et al.: Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 2006; 54: 606-7.
22. Bliuc D, Eisman JA, Center JR: A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int 2006; 17: 1309-17.
23. Solomon DH, Polinski JM, Stedman M et al.: Improving care of patients at risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 2007; 22: 362-7.
24. Schousboe JT, Ensrud KE, Nyman JA, Melton LJ, Kane RL: Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly costeffective for elderly women. J Am Geriatr Soc 2005; 53: 1697-704.